LeonaBio, Inc. Common Stock
Veridion Score
Composite trend over time
Why is LONA moving today?
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LONA.
LONA insider activity
LeonaBio, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$56K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-04 | Renninger Robert | Insider | sell | $5.37 | 906 | 15,851 | $5K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Worthington Mark | Insider | sell | $5.37 | 1,328 | 18,376 | $7K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | CHURCH KEVIN | Insider | sell | $5.37 | 1,359 | 25,178 | $7K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | San Martin Javier | Insider | sell | $5.37 | 1,720 | 15,887 | $9K | SEC Form 4 |
| 2026-03-05 | 2026-03-04 | Litton Mark James | Insider | sell | $5.37 | 5,156 | 57,926 | $28K | SEC Form 4 |
LONA contract awards, year to date.
Public federal awards linked to this ticker.
LONA lobbying filings, year to date.
Registered lobbying filings matched to LeonaBio, Inc. Common Stock.